Stock PHAS.Q PHASEBIO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. PhaseBio Pharmaceuticals, Inc.

Equities

PHAS.Q

US7172241090

End-of-day quote OTC Markets
Other stock markets
 23:00:00 09/06/2024 BST 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for PhaseBio Pharmaceuticals, Inc. 0.00% 0.00%
05-13 Amended Disclosure Statement Conditionally Approved for PhaseBio Pharmaceuticals, Inc. CI
04-19 First Amended Combined Liquidation Plan and Disclousre Statement Filed by PhaseBio Pharmaceuticals, Inc. CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Cowen Downgrades PhaseBio Pharmaceuticals to Market Perform From Outperform
MT
Stifel Nicolaus Downgrades PhaseBio Pharmaceuticals to Hold From Buy, Sets $1 Price Target
MT
Needham Downgrades PhaseBio Pharmaceuticals to Hold from Buy
MT
William Blair Downgrades PhaseBio Pharmaceuticals to Market Perform From Outperform
MT
Needham Adjusts Price Target on PhaseBio Pharmaceuticals to $8 From $10, Reiterates Buy Rating
MT
Needham Adjusts PhaseBio Pharmaceuticals' Price Target to $10 from $15, Keeps Buy Rating
MT
PHASEBIO PHARMACEUTICALS : Needham Adjusts Price Target on PhaseBio Pharmaceuticals to $19 From $18, Maintains Buy Rating
MT
PHASEBIO PHARMACEUTICALS : Stifel Adjusts PhaseBio Pharmaceuticals' Price Target to $8 from $11, Keeps Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHAS.Q Stock
  4. News PhaseBio Pharmaceuticals, Inc.
  5. Analyst Reco.